Why Evogene (EVGN) Stock Is Trading Higher

Evogene Ltd (NASDAQ: EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to sell its castor seeds for sustainable biofuel production, with initial purchase orders of $9.1 million

Evogene Ltd (NASDAQ:EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to sell its castor seeds for sustainable biofuel production, with initial purchase orders of $9.1 million.

According to Casterra’s analysis, the purchase orders disclosed today have the potential to facilitate the production of approximately 1.5% of the existing global demand for non-fossil oil intended for biodiesel applications.

See Also: Why UPS Stock Is Sliding Wednesday

Casterra, operating as a subsidiary of Evogene, plays a leading role in advancing the development of exclusive high-yield castor plant varieties.

According to data from Benzinga Pro, EVGN has a 52-week high of $1.30 and a 52-week low of $0.55.

Total
0
Shares
Related Posts
Read More

Altamira Therapeutics Provides Business Update; Company Is Striving To Sell Or Partner Its Other Legacy Assets, Inner Ear Therapeutics; Agreed Upon Sale Assets To The European Family Office Did Not Close As The Buyer Was Not Able To Secure Financing

Similarly, the Company is striving to sell or partner its other legacy assets – inner ear therapeutics. Unfortunately, the agreed upon sale of these assets to a European family office (the "Buyer") did

CYTO